The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2020

New regulation 13B of the National Health Service (Charges for Drugs and Appliances) Regulations 2015

29.  After regulation 13A of the National Health Service (Charges for Drugs and Appliances) Regulations 2013(1) (exemption from charges: supply of a smaller quantity of a product in accordance with a SSP) insert—

“Coronavirus and influenza vaccinations and immunisations

13B.— (1) No charge is payable under these Regulations in respect of the supply or administration to an eligible person of a medicinal product used for vaccination or immunisation against coronavirus or influenza virus.

(2) In this regulation—

“coronavirus” has the meaning given in section 1(1) of the Coronavirus Act 2020(2); and

“eligible person” means a person who is of a class or description that means they would be entitled to be supplied with the medicinal product, or have it administered to them, in accordance with—

(a)

a national patient group direction under regulation 233 of the Human Medicines Regulations 2012(3) (exemption for supply etc under a PGD by a person conducting a retail pharmacy business), signed on behalf of the Board in accordance with paragraph (5)(a) of that regulation; or

(b)

a national protocol under regulation 247A of the Human Medicines Regulations 2012(4) (protocols relating to coronavirus and influenza vaccinations and immunisations) approved by the Secretary of State,

whether or not the medicinal product is supplied or administered to that person in accordance with such a patient group direction or protocol.”.

(1)

S.I. 2015/570; regulation 13A was inserted by S.I. 2019/990.

(2)

2020 c. 7.

(3)

Regulation 233 has been amended by S.I. 2013/235, 2015/1503, 2019/775 and 2020/1125.

(4)

Inserted by S.I. 2020/1125.